World's Best Scientists 2026 revealed!
Chiara Castelli

Chiara Castelli

D-Index & Metrics

Immunology

D-Index
56
Citations
17926
World Ranking
3671
National Ranking
151

Overview

Chiara Castelli is affiliated with the University of Milan in Italy and has contributed extensively to the field of medicine, focusing on oncology and immunology among other subfields. Their research output includes 36 publications primarily related to medicine, with significant emphasis in oncology, immunology, pulmonary and respiratory medicine, cancer research, and rheumatology.

The scientist's recent works cover key areas such as cancer immunotherapy, immune cell functions, extracellular vesicles, and microRNA regulation. Specific main topics of research addressed by Chiara Castelli include:

  • Cancer Immunotherapy and Biomarkers
  • Immune cells in cancer
  • Sarcoma Diagnosis and Treatment
  • Extracellular vesicles in disease
  • MicroRNA in disease regulation
  • Immune Cell Function and Interaction
  • Ferroptosis and cancer prognosis

Chiara Castelli has published several papers recently, including:

  • Extracellular vesicles in anti-tumor immunity, 2021, Seminars in Cancer Biology
  • The microRNA let-7b-5p Is Negatively Associated with Inflammation and Disease Severity in Multiple Sclerosis, 2021, Cells
  • Molecular Determinants of Soft Tissue Sarcoma Immunity: Targets for Immune Intervention, 2021, International Journal of Molecular Sciences
  • Y90-radioembolisation in hepatocellular carcinoma induces immune responses calling for early treatment with multiple checkpoint blockers, 2022, Gut
  • microRNAs Shape Myeloid Cell-Mediated Resistance to Cancer Immunotherapy, 2020, Frontiers in Immunology

The frequent co-authors collaborating with Chiara Castelli include Licia Rivoltini, Viviana Vallacchi, Laura Bergamaschi, Luca Lalli, and Monica Rodolfo. These collaborations have been reflected in multiple joint publications, indicating ongoing research partnerships.

Their research has been published across several notable scientific venues. The publications are often found in:

  • Annals of Oncology
  • Seminars in Cancer Biology
  • Cells
  • International Journal of Molecular Sciences
  • Gut

Best Publications

  • Phenotypic characterization of human colorectal cancer stem cells

    Piero Dalerba;Scott J. Dylla;In Kyung Park;Rui Liu

  • A listing of human tumor antigens recognized by T cells.

    Nicolina Renkvist;Chiara Castelli;Paul F. Robbins;Giorgio Parmiani

  • Identification of a New Subset of Myeloid Suppressor Cells in Peripheral Blood of Melanoma Patients With Modulation by a Granulocyte-Macrophage Colony-Stimulation Factor–Based Antitumor Vaccine

    Paola Filipazzi;Roberta Valenti;Veronica Huber;Lorenzo Pilla

  • Induction of lymphocyte apoptosis by tumor cell secretion of FasL-bearing microvesicles.

    Giovanna Andreola;Licia Rivoltini;Chiara Castelli;Veronica Huber

  • A listing of human tumor antigens recognized by T cells: March 2004 update

    Luisa Novellino;Chiara Castelli;Giorgio Parmiani

  • Cancer acidity: An ultimate frontier of tumor immune escape and a novel target of immunomodulation

    Veronica Huber;Chiara Camisaschi;Angela Berzi;Simona Ferro

  • Hepatocellular Carcinoma Is Associated With Gut Microbiota Profile and Inflammation in Nonalcoholic Fatty Liver Disease.

    Francesca Romana Ponziani;Sherrie Bhoori;Chiara Castelli;Lorenza Putignani

  • Classification of current anticancer immunotherapies

    Lorenzo Galluzzi;Erika Vacchelli;José Manuel Bravo-San Pedro;Aitziber Buqué

  • Cancer immunotherapy with peptide-based vaccines: what have we achieved? Where are we going?

    Giorgio Parmiani;Chiara Castelli;Piero Dalerba;Roberta Mortarini

  • Opposite immune functions of GM-CSF administered as vaccine adjuvant in cancer patients

    Giorgio Parmiani;C. Castelli;L. Pilla;M. Santinami

  • LAG-3 expression defines a subset of CD4(+)CD25(high)Foxp3(+) regulatory T cells that are expanded at tumor sites.

    Chiara Camisaschi;Chiara Casati;Francesca Rini;Michela Perego

  • Tumor escape from immune recognition: lethal recurrent melanoma in a patient associated with downregulation of the peptide transporter protein TAP-1 and loss of expression of the immunodominant MART-1/Melan-A antigen.

    Markus J. Maeurer;Susanne M. Gollin;Dina Martin;William Swaney

  • Immunity to cancer: attack and escape in T lymphocyte–tumor cell interaction

    Licia Rivoltini;Matteo Carrabba;Veronica Huber;Chiara Castelli

  • Mass spectrometric identification of a naturally processed melanoma peptide recognized by CD8+ cytotoxic T lymphocytes.

    Chiara Castelli;Walter J. Storkus;Markus J. Maeurer;Dina M. Martin

  • Modulation of Pulmonary Microbiota by Antibiotic or Probiotic Aerosol Therapy: A Strategy to Promote Immunosurveillance against Lung Metastases

    Valentino Le Noci;Simone Guglielmetti;Stefania Arioli;Chiara Camisaschi

  • Human heat shock protein 70 peptide complexes specifically activate antimelanoma T cells.

    Chiara Castelli;Anne-Marie T. Ciupitu;Francesca Rini;Licia Rivoltini

  • Unique human tumor antigens : Immunobiology and use in clinical trials

    Giorgio Parmiani;Annamaria De Filippo;Luisa Novellino;Chiara Castelli

  • Identification of epitope mimics recognized by CTL reactive to the melanoma/melanocyte-derived peptide MART-1((27-35))

    Douglas J. Loftus;Chiara Castelli;Timothy M. Clay;Paola Squarcina

  • Immunology and immunotherapy of colorectal cancer.

    Piero Dalerba;Cristina Maccalli;Chiara Casati;Chiara Castelli

  • T-cell recognition of melanoma-associated antigens.

    Chiara Castelli;Licia Rivoltini;Giovanna Andreola;Matteo Carrabba

  • Identification of Epitope Mimics Recognized by CTL Reactive to the Melanoma/Melanocyte-derived Peptide

    Douglas J. Loftus;Chiara Castelli;Timothy M. Clayfi;Paola Squarcina

Frequent Co-Authors

Licia Rivoltini
Licia Rivoltini Fondazione IRCCS Istituto Nazionale dei Tumori
Giorgio Parmiani
Giorgio Parmiani University of Siena
Markus Maeurer
Markus Maeurer Champalimaud Foundation
Andrea Anichini
Andrea Anichini Fondazione IRCCS Istituto Nazionale dei Tumori
Antonello Villa
Antonello Villa University of Milano-Bicocca
Silvia Stacchiotti
Silvia Stacchiotti University of Milan
Silvana Pilotti
Silvana Pilotti University of Milan
Michael T. Lotze
Michael T. Lotze University of Pittsburgh
Vincenzo Mazzaferro
Vincenzo Mazzaferro University of Milan
Paolo G. Casali
Paolo G. Casali University of Milan

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in expanding their expertise beyond Immunology, exploring related healthcare degrees can open up diverse career opportunities. Programs such as accelerated NP programs offer a fast-tracked route to becoming a Nurse Practitioner, blending advanced clinical skills with immunological knowledge.

Individuals without a nursing background might consider 12-month accelerated nursing programs online for non nurses, which are designed to transition non-nurses into competent healthcare professionals quickly and effectively. These programs can complement immunology expertise by enhancing patient care capabilities.

For those seeking the quickest pathway to nursing licensure, 12-month accelerated nursing programs provide streamlined options. These intensive courses offer a balance of speed and quality, critical for timely entry into healthcare roles connected with immunology research or practice.

Additionally, the best easiest LPN programs to get into are ideal for those seeking practical nursing credentials with flexible admissions. Such programs can serve as stepping stones toward more advanced immunology-related healthcare careers.

Best Scientists Citing Chiara Castelli

Trending Scientists

Recently Published Articles